Caryn Bowe
29Patents
20h-index
13Co-inventors
78Inventor score
Filing activity: Oct 9, 2002 → Oct 11, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7138371B2 | Remodeling and glycoconjugation of peptides | Chemistry; Metallurgy | 90 | Expired |
| US7125843B2 | Glycoconjugates including more than one peptide | Chemistry; Metallurgy | 82 | Expired |
| US7179617B2 | Factor IX: remolding and glycoconjugation of Factor IX | Human Necessities | 65 | Expired |
| US7439043B2 | Galactosyl nucleotide sugars | Chemistry; Metallurgy | 65 | Expired |
| US8063015B2 | Glycopegylation methods and proteins/peptides produced by the methods | Chemistry; Metallurgy | 53 | Active |
| US7276475B2 | Remodeling and glycoconjugation of peptides | Chemistry; Metallurgy | 52 | Expired |
| US7473680B2 | Remodeling and glycoconjugation of peptides | Human Necessities | 52 | Expired |
| US7265084B2 | Glycopegylation methods and proteins/peptides produced by the methods | Chemistry; Metallurgy | 48 | Expired |
| US7416858B2 | Pharmaceutical compositions of glycoconjugates | Chemistry; Metallurgy | 48 | Expired |
| US7214660B2 | Erythropoietin: remodeling and glycoconjugation of erythropoietin | Emerging Cross-Sectional Technologies | 47 | Expired |
| US7157277B2 | Factor VIII remodeling and glycoconjugation of Factor VIII | Human Necessities | 45 | Expired |
| US7265085B2 | Glycoconjugation methods and proteins/peptides produced by the methods | Human Necessities | 42 | Expired |
| US7226903B2 | Interferon beta: remodeling and glycoconjugation of interferon beta | Chemistry; Metallurgy | 41 | Expired |
| US7399613B2 | Sialic acid nucleotide sugars | Human Necessities | 38 | Expired |
| US7696163B2 | Erythropoietin: remodeling and glycoconjugation of erythropoietin | Human Necessities | 37 | Expired |
| US7297511B2 | Interferon alpha: remodeling and glycoconjugation of interferon alpha | Human Necessities | 37 | Expired |
| US7173003B2 | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF | Chemistry; Metallurgy | 36 | Expired |
| US7956032B2 | Glycopegylated granulocyte colony stimulating factor | Human Necessities | 27 | Active |
| US8008252B2 | Factor VII: remodeling and glycoconjugation of Factor VII | Chemistry; Metallurgy | 27 | Active |
| US8716240B2 | Erythropoietin: remodeling and glycoconjugation of erythropoietin | Emerging Cross-Sectional Technologies | 22 | Active |
| US8716239B2 | Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSF | Chemistry; Metallurgy | 17 | Active |
| US8853161B2 | Glycopegylation methods and proteins/peptides produced by the methods | Chemistry; Metallurgy | 12 | Active |
| US8791070B2 | Glycopegylated factor IX | Chemistry; Metallurgy | 9 | Active |
| US8076292B2 | Factor VIII: remodeling and glycoconjugation of factor VIII | Human Necessities | 6 | Active |
| US8404809B2 | Glycopegylated factor IX | Chemistry; Metallurgy | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.